SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12) GlobeNewswire September 04, 2025 Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistance Additional poster presentations highlight SCY-247's broad spectrum of […]

Shirofune Enhances Amazon Ads Automation with AMC Integration to Enable Lifetime Value-Based Optimization Advertisers gain access to key metrics, including CAC, New Customer ROAS, and predicted LTV for more strategic campaign automation GlobeNewswire September 04, 2025 EL SEGUNDO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — Shirofune, the leading platform for digital advertising automation, today announced

Urbana Corporation – Renewal of Normal Course Issuer Bid GlobeNewswire September 04, 2025 /NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Sept. 04, 2025 (GLOBE NEWSWIRE) — Urbana Corporation (“Urbana”) (TSX & CSE: URB & URB.A) announced today that the Toronto Stock Exchange (“TSX”) has accepted its notice of

Mandragora: Whispers of the Witch Tree Now Available on PlayStation(R)5 and Nintendo Switch in Asia GlobeNewswire September 04, 2025 SINGAPORE, Sept. 04, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd. (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that “Mandragora: Whispers of the Witch Tree” is now available

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming GlobeNewswire September 04, 2025 The Pure Impact VIP(TM) standalone device represents a major extension of the Pure Impact(TM) product line and introduces an all-in-one independent unit Standalone device is launched with an enhanced Pure Impact(TM)

BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO) GlobeNewswire September 04, 2025 NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE), a clinical-stage company advancing

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management GlobeNewswire September 04, 2025 NPM-139 has potential to provide Wegovy(R)-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance Preparations for dose-ranging Phase 2 study

U.S. Clean Energy Market Projected to Reach $198 Billion by 2033 Driven by Record Renewable Deployments & Advancing Technologies GlobeNewswire September 04, 2025 PALM BEACH, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – A recent report from a Clean Energy industry insider said that: “The U.S. clean energy market is

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for Ozanimod Capsules (a generic version of ZEPOSIA®) for the U.S. market. Synthon has a pending

Transaction enhances manufacturing capabilities Global diversified manufacturer Milliken & Company has acquired the assets of Highland Industries, Inc. in Cheraw, South Carolina. The transaction strengthens Milliken's domestic operations and position in technical textiles. https://mma.prnewswire.com/media/2254813/Milliken_and_Company_Logo.jpg “This acquisition bolsters the capabilities of Milliken's technical textiles business to benefit our customers,” said Halsey Cook, president and CEO of